Thus, in the absence of host CCR2, tumor cell-derived CCL2 that is induced downstream of cancer cell-expressed TRAIL-R (Figure 6C) fails to promote the presence of alternatively activated myeloid cells in the tumor microenvironment, coincident with diminished tumor growth. The gene discussed is CCL2; the disease is cancer.